A Post-Pandemic Era White Paper Published in Nature Magazine

European Union Clinical Trials Regulation Came into Effect

Biden reignites the Cancer Moonshot, setting ambitious goals: to reduce the death rate from cancer by at least 50 percent over the next 25 years

International Cancer Coalition Launch

In 2021, the International Cancer Coalition officially launched at the Bloomberg New Economy Forum in Singapore.

Forbes China Healthcare Summit opens the door to “Ping-Pong Diplomacy of the 21st Century”

The 2021 Forbes China Healthcare Summit was held to discuss the theme of “Advance the Global Fight Against Cancer and Achieve a Moonshot in the Post-Pandemic Era.”

FDA granted accelerated approval to sotorasib (Lumakras)

A pandemic-era CodeBreaK100 international trial led to FDA accelerated approval of sotorasib (Lumakras), the first targeted drug against KRAS, the commonest oncogene driver in human cancers which was previously thought to be uncurable.

Forbes China Healthcare Summit launched

Forbes China Healthcare Summit launched, bringing together leading academic, industry, and government stakeholders in the U.S. and China to collaborate on international clinical trials in the COVID-19 pandemic era.

FDA initiates Project Orbis

The U.S. FDA initiated Project Orbis to provide a framework for the submission and review of oncology products among international government regulatory agencies, with Australia and Canada as the first...